BOEHRINGER INGELHEIM INTERNATIONAL GMBH;BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG
发明人:
申请号：
EP05823930.2
公开号：
EP1830843B1
申请日:
2005.12.21
申请国别(地区):
EP
年份:
2012
代理人:
摘要：
The present invention relates to the use of indolinones of general formula substituted in the 6 position, wherein R 1 to R 5 and X are defined as in claim 1, the isomers and the salts thereof, particularly the physiologically acceptable salts thereof, as a medicament for the prevention or treatment of specific fibrotic diseases.
